1-5 of 5
Jürgen Krauter, Prof. Dr. med.
Close
Sort by
Journal Articles

Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia

Katharina Wagner, MD, Anna Both, Frederik Damm, MD, Felicitas Thol, MD, Gudrun Göhring, MD, Michael Heuser, MD, Oliver G. Ottmann, MD, Michael Lübbert, MD, Mohammed Wattad, MD, Lothar Kanz, MD, Günther Schlimok, MD, Aruna Raghavachar, MD, Walter Fiedler, MD, Hartmut Kirchner, MD, Wolfram Brugger, MD, Brigitte Schlegelberger, Gerhard Heil, MD, Arnold Ganser, Jürgen Krauter, Prof. Dr. med.
Journal: Blood
Blood (2012) 120 (21): 1381.
https://doi.org/10.1182/blood.V120.21.1381.1381
Published: 2012
Journal Articles

Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients

Felicitas Thol, MD, Britta Kölking, Iris H.I.M. Hollink, MD, PhD, Frederik Damm, MD, Marry M. van den Heuvel-Eibrink, C. Michel Zwaan, MD, PhD, Gesine Bug, Oliver G. Ottmann, MD, Katharina Wagner, MD, Michael A Morgan, PhD, Wolf-Karsten Hofmann, Gudrun Göhring, MD, Brigitte Schlegelberger, Jürgen Krauter, Prof. Dr. med., Arnold Ganser, Michael Heuser, MD
Journal: Blood
Blood (2012) 120 (21): 1402.
https://doi.org/10.1182/blood.V120.21.1402.1402
Published: 2012
Journal Articles

Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation

Felicitas Thol, MD, Christian Koenecke, Sofia Kade, Liu Huang, Uwe Platzbecker, MD, Christian Thiede, Thomas Schroeder, MD, Guido Kobbe, MD, Martin Gehlhaar, Robin Bollin, Stefanie Buchholz, MD, Michael Stadler, MD, Gudrun Göhring, MD, Elke Dammann, Moritz Kleine, MD, Wiebke Brauns, Michael Hallensleben, MD, Brigitte Schlegelberger, Jürgen Krauter, Prof. Dr. med., Arnold Ganser, Nicolaus Kröger, Michael Heuser, MD
Journal: Blood
Blood (2012) 120 (21): 357.
https://doi.org/10.1182/blood.V120.21.357.357
Published: 2012
Journal Articles

Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Study (ClinicalTrials.gov No. NCT01180322)

Richard F Schlenk, MD, Wolfgang Herr, MD, Gerald Wulf, Helmut R Salih, MD, Jürgen Krauter, Prof. Dr. med., Hans Guenter Derigs, MD, Andrea Kündgen, Mark Ringhoffer, MD, Uwe M. Martens, MD, Bernd Hertenstein, Martin Griesshammer, MD, PhD, Michael Girschikofsky, MD, Helga Bernhard, MD, Jens Kersten, MD, Maria von Lilienfeld-Toal, MD, Elisabeth Koller, MD, Elisabeth Lange, MD, Jörg Westermann, MD, Daniela Späth, MSc, Gudrun Göhring, MD, Veronica Teleanu, MD, Axel Benner, Dipl.Stat., Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 412.
https://doi.org/10.1182/blood.V120.21.412.412
Published: 2012
Journal Articles

Global Phosphoproteome Analysis of AML Bone Marrow Reveals Predictive Markers for the Treatment with AC220

Christoph Schaab, Dr., Felix Oppermann, Dr., Heike Pfeifer, Dr. med., Martin Klammer, Dr., Andreas Tebbe, Dr., Thomas Oellerich, Dr. med., Jürgen Krauter, Prof. Dr. med., Mark J. Levis, MD, PhD, Alexander E Perl, MD, Henrik Daub, Dr., Björn Steffen, MD, Klaus Godl, Dr., Hubert Serve, Prof. Dr. med.
Journal: Blood
Blood (2012) 120 (21): 786.
https://doi.org/10.1182/blood.V120.21.786.786
Published: 2012